These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 3316490)
1. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. Schneier FR; Siris SG J Nerv Ment Dis; 1987 Nov; 175(11):641-52. PubMed ID: 3316490 [TBL] [Abstract][Full Text] [Related]
2. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. Potvin S; Stip E; Roy JY Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543 [TBL] [Abstract][Full Text] [Related]
4. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients]. Lambert M; Haasen C; Mass R; Krausz M Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658 [TBL] [Abstract][Full Text] [Related]
5. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse. Lammertink M; Löhrer F; Kaiser R; Hambrecht M; Pukrop R Acta Psychiatr Scand; 2001 Nov; 104(5):361-6. PubMed ID: 11722317 [TBL] [Abstract][Full Text] [Related]
6. Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Rosenthal RN; Hellerstein DJ; Miner CR Compr Psychiatry; 1994; 35(2):91-8. PubMed ID: 8187482 [TBL] [Abstract][Full Text] [Related]
7. Drug abuse in schizophrenia and bipolar disorder. Miller FT; Busch F; Tanenbaum JH Am J Drug Alcohol Abuse; 1989; 15(3):291-5. PubMed ID: 2763984 [TBL] [Abstract][Full Text] [Related]
9. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645 [TBL] [Abstract][Full Text] [Related]
10. Impact of substance abuse on the course and outcome of schizophrenia. Turner WM; Tsuang MT Schizophr Bull; 1990; 16(1):87-95. PubMed ID: 2185537 [TBL] [Abstract][Full Text] [Related]
11. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Dixon L; Haas G; Weiden P; Sweeney J; Frances A Schizophr Bull; 1990; 16(1):69-79. PubMed ID: 2185536 [TBL] [Abstract][Full Text] [Related]
12. [Drug use and dependence in schizophrenia]. Arias Horcajadas F; Padín Calo JJ; Fernández González MA Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(6):379-89. PubMed ID: 9477606 [TBL] [Abstract][Full Text] [Related]
13. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome. Werner FM; Covenas R Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847 [TBL] [Abstract][Full Text] [Related]
14. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Krystal JH; D'Souza DC; Madonick S; Petrakis IL Schizophr Res; 1999 Mar; 35 Suppl():S35-49. PubMed ID: 10190224 [TBL] [Abstract][Full Text] [Related]
15. [Why schizophrenic patients use psychoactive substances?]. Sawicka M Psychiatr Pol; 2004; 38(4):723-6. PubMed ID: 15518319 [TBL] [Abstract][Full Text] [Related]
16. Inner-city substance abuse patterns: a study of psychiatric inpatients. Fernandez-Pol B; Bluestone H; Mizruchi MS Am J Drug Alcohol Abuse; 1988; 14(1):41-50. PubMed ID: 3265029 [TBL] [Abstract][Full Text] [Related]
17. Changing patterns of illicit substance use among schizophrenic patients: 1984-1996. Patkar AA; Alexander RC; Lundy A; Certa KM Am J Addict; 1999; 8(1):65-71. PubMed ID: 10189516 [TBL] [Abstract][Full Text] [Related]
18. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings. Thoma P; Daum I Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122 [TBL] [Abstract][Full Text] [Related]
19. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. Potvin S; Pampoulova T; Mancini-Marië A; Lipp O; Bouchard RH; Stip E J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):796-8. PubMed ID: 16705205 [TBL] [Abstract][Full Text] [Related]
20. The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan. Tanibuchi Y; Matsumoto T; Funada D; Shimane T Neuropsychopharmacol Rep; 2018 Dec; 38(4):189-196. PubMed ID: 30341809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]